Prenatal exposure to elevated testosterone levels induces adult life hypertension associated with selective impairments in endothelium-derived hyperpolarizing factor (EDHF)-mediated relaxation in mesenteric arteries. We tested whether the angiotensin-converting enzyme inhibitor enalapril restores EDHF function through regulating the activities of small (Kcnn3) and intermediate (Kcnn4) conductance calcium-activated potassium channels in mesenteric arteries. Pregnant SpragueDawley rats were injected subcutaneously with vehicle or testosterone propionate (0.5 mg/kg/day from Gestation Day 15 to 19), and their 6-mo-old adult male offspring were examined. A subset of rats in these two groups was given enalapril (40 mg/ kg/day) for 2 wk through drinking water. Blood pressures were assessed through carotid arterial catheter and endotheliumdependent mesenteric arterial EDHF relaxation, using wire myography. Ace and Kcnn3 and Kcnn4 channel expression levels were also examined. Renal and vascular Ace expression and plasma angiotensin II levels were increased in testosterone offspring. Blood pressure levels were significantly higher in testosterone offspring than in controls, and treatment with enalapril significantly attenuated blood pressure in testosterone offspring. EDHF relaxation in testosterone offspring was reduced compared to that in controls, and it was significantly restored by enalapril treatment. Kcnn4 channel expression and function were similar between control and testosterone rats, but it was not affected by enalapril treatment. Relaxation mediated by Kcnn3 was impaired in testosterone offspring, and it was normalized by enalapril treatment. Furthermore, enalapril treatment restored expression levels of Kcnn3 channels. These findings suggest that enalapril has a positive influence on endothelial function with improvement in EDHF relaxation through normalization of Kcnn3 expression and activity.
INTRODUCTION
Endothelium plays a major role in the regulation of vascular tone. It is capable of exerting a profound relaxing influence on underlying smooth muscle through the actions of nitric oxide (NO) and prostacyclin (PGI2) in addition to the more elusive endothelium-derived hyperpolarizing factor (EDHF) [1] . Endothelial hyperpolarization mediated by Ca 2þ -activated K þ (K Ca ) channels, such as small (Kcnn3) and intermediate (Kcnn4) conductance K Ca channels, has been suggested to play a critical role in initiating EDHF-type relaxation responses in the arteries of many species, including humans [2] [3] [4] [5] . The contribution made by EDHF to relaxation is dependent on vessel size. It is suggested that NO is more important in large vessels, whereas EDHF is thought to be more important in small mesenteric arteries, which participate actively in the regulation of systemic peripheral resistance and, thus, blood pressure [6] [7] [8] . Also, the expression levels of Kcnn3 and Kcnn4 channels are higher in fourth-order mesenteric arteries than in first-order vessels, stressing the importance of these channels in smaller vessels, where the role of EDHF is more pronounced [8] . Studies using transgenic mice have shown that Kcnn3 and Kcnn4 channels exert a profound hyperpolarizing influence in resistance arteries and that suppression of Kcnn3 [9] and Kcnn4 [10] channel expression or deletion [11] causes pronounced and reversible hypertension. Furthermore, openers of Kcnn3 and Kcnn4 channels reduce blood pressure in mice [12] and dogs [13] . These observations indicate the significance of Kcnn3 and Kcnn4 channels in regulating vasomotor tone and blood pressure. This notion is of particular importance in appreciating the mechanism(s) underlying hypertension and its therapy. It is well established that hypertension has developmental origins with exposure to adverse insults during the prenatal period, leading to the development of endothelial dysfunction and elevated blood pressure during adult life [14] . It is important to note that endothelial dysfunction has been shown to be a common denominator in all types of hypertension regardless of its pathogenesis [15] . Decreased generation of EDHF, which is particularly critical in resistance arteries, has been shown to contribute to impaired endothelium-dependent vasodilation in genetic as well as developmentally programmed hypertension [16] [17] [18] [19] [20] [21] [22] [23] . Recently, reduced expression of Kcnn3 channel mRNA, but not Kcnn4, was observed in mesenteric arteries of rats programmed to develop hypertension following prenatal exposure to testosterone (T) [17] . However, the underlying mechanism that contributes to reduction in expression and function of EDHF components remains largely unclear.
Modulation of the renin-angiotensin system (RAS) by angiotensin-converting enzyme (ACE) inhibitors and angio-tensin II (Ang II) receptor blockers has been shown to have vascular protective effects [24] [25] [26] [27] [28] . Studies have demonstrated that inhibition of RAS has beneficial endothelial effects because it increases expression and activity of endothelial NO synthase (eNOS) and in turn increases NO bioavailability and function [29] ; however, little information is available to indicate whether the RAS blockade might correct EDHFmediated signaling. Thus, the aims of our study were to assess whether enalapril (an ACE inhibitor) modifies EDHF function and its associated K Ca channel expression and functions in mesenteric arteries of prenatally programmed hypertensive rats.
MATERIALS AND METHODS
All experimental procedures were performed in accordance with U.S. National Institutes of Health guidelines (NIH publication no. 85-23, revised 1996) with approval by the Animal Care and Use Committee at the University of Texas Medical Branch. Timed-pregnancy Sprague-Dawley rats (Harlan, Houston, TX) were divided into two groups on Gestational Day 14, and one group received daily subcutaneous injections of T propionate (Sigma, St. Louis, MO) from Gestational Day 15 to 19, 0.5 mg/kg body weight/day (n ¼ 8). The other group received vehicle (sesame oil, n ¼ 8). This dosage and duration of exposure is commonly used to mimic plasma T levels (2-fold increase) observed in pre-eclamptic women [30] [31] [32] [33] . Dams in both groups were allowed to deliver at term, and birth weights of pups were recorded. The number of pups in the control and the T litters was adjusted to 10 pups per dam to ensure equal nutrient access for all offspring (pups with weights at each extreme were sacrificed). The male-to-female pup ratios remained equivalent after culling, when possible. Pups were weaned at 3 wk of age, and only the males were used for this study. When pups were 6 mo of age, their mean arterial pressure (MAP) was monitored using a carotid arterial catheter. Following blood pressure measurements, the animals were sacrificed, plasma was separated, and kidney and mesenteric arteries were isolated. A portion of the mesenteric arteries was used for vascular reactivity studies, and the remaining arteries were quickly frozen for RNA isolation. Plasma T and Ang II levels in the samples were measured using a testosterone ELISA kit (Enzo Life Sciences, Farmingdale, NY) and an Ang II enzyme immunoassay kit (Phoenix Pharmaceutical Inc., Burlingame, CA), respectively, as in our previous publications [31, 34] . One offspring from each litter was studied, and n refers to the number of litters studied.
Experimental Procedures
Mean arterial pressure. MAPs were determined in 6-mo-old conscious, freely moving offspring of control and T dams, using indwelling carotid arterial catheters as described in our previous publication [35] . Briefly, rats under anesthesia (isoflurane; Henry Schein Animal Health, Dublin, OH) were surgically instrumented with flexible catheters (PE 50 tubing) in the right carotid artery. Catheters were tunneled to the nape of the neck and exteriorized. After a 24-h recovery period, when the animals were fully conscious and in a free-moving state, the catheter was connected to a pressure transducer, and arterial blood pressure was obtained using a data acquisition system (product DBP001 direct blood pressure system (Kent Scientific, Litchfield, CT) and Workbench for Windows software (Microsoft, Redmond, WA). Following a 30-min stabilization period, the arterial pressure was monitored continuously for 30 min and averaged to determine baseline values.
Enalapril treatment. A subset of 6-mo-old male offspring was given the ACE inhibitor enalapril (250 mg/L) in their drinking water for 2 wk. All treated groups received a similar dose of enalapril, 40 mg/kg/day, based on average daily water consumption, 65 ml/day, and average daily body weight, 0.43 kg; no significant differences were found between groups. Following enalapril treatment, changes in arterial pressure were recorded using an indwelling arterial catheter.
Ex vivo vascular reactivity studies. Rats were sacrificed by CO 2 inhalation, and the mesenteric arcade was removed. Resistance mesenteric arteries (2-mm segments of the fourth-order branch of the superior mesenteric artery, 150-to 200-lm diameter) were dissected free of fat and connective tissue and mounted in Mulvany-style isometric wire myographs (Danish Myotechnology, Aarhaus, Denmark) for vessel reactivity assessment. Vessels were maintained at 378C in a physiological Krebs buffer composed of (mM): NaCl, 120; NaHCO 3 , 25; KCl, 4.8; NaH 2 PO 4 , 1.2; MgSO 4 , 1.2; dextrose, 11.0; CaCl 2 , 1.8 aerated with 95% O 2 , and 5% CO 2 (pH ¼ 7.4). Rings were bathed in 6-ml Krebs buffer and allowed to equilibrate for 60 min before normalizing to an internal diameter of 0.9 of L 13.3kPa by using normalization software (Myodata; Danish Myotechnology). The rings were then assessed for vascular function. Data were captured using a Power Lab data acquisition system (AD Instruments, Colorado Springs, CO). The presence of intact endothelium in vascular preparations was confirmed by observing the relaxation response to acetylcholine (ACh; 10 À6 M) in rings precontracted with phenylephrine (PE; 10 À6 M), as described previously [36] . In our preliminary experiment, the concentration response curves for PE-induced contractions were not different among the four groups. Once the PE-induced contraction (approximately at 80% of maximally effective dose, i.e., ED 80 concentration) had stabilized, relaxation responses to cumulative concentrations of ACh (10 À10 to 10 À5 M) were elicited. The EDHF-mediated component of ACh vasorelaxation was assessed after inhibiting NO production with NG-nitro-L-arginine methyl ester (L-NAME; 10 À4 M) and PGI2 synthesis with indomethacin (10 À5 M) for 30 min. In some experiments, the EDHF component of ACh relaxation was generated in the presence of the Kcnn3 inhibitor apamin (10 À7 M for 30 min) [4, 37, 38] or the Kcnn4 inhibitor TRAM-34 (10 À6 M for 30 min) [4, 37, 38] . Endothelium-independent relaxation responses to levcromakalim (10 À10 to 10 À5 M) in PE-precontracted rings were also determined.
Quantitative Real-Time qRT-PCR
Total RNA was isolated from mesenteric arties by using TRIzol reagent (Invitrogen, Carlsbad, CA). All RNA isolates were made DNA free by treatment with DNase and further purified with an RNeasy clean-up kit (QIAGEN, Inc., Valencia, CA). Total RNA concentration and purity were determined using an ND-1000 model Nanodrop spectrophotometer (Thermo Fisher Scientific, Newark, DE). Two micrograms of total RNA were reverse transcribed using a modified Maloney murine leukemia virus-derived reverse transcriptase (New England Biolabs Inc., Ipswich, MA) and a blend of oligo(dT) and random hexamer primers (Invitrogen). The reaction was carried out at 288C for 15 min and then at 428C for 50 min. It was stopped by heating at 948C for 5 min, followed by 48C, and then stored at À208C until further analysis. One microliter of the resulting cDNA was amplified by real-time RT-PCR, using SYBR Green 0 PCR conditions were 10 min at 958C for 1 cycle, 15 sec at 958C, 30 sec at 608C, and 15 sec at 728C for 40 cycles, with a final dissociation step (0.05 sec at 658C and 0.5 sec at 958C). Results were calculated using the 2 -DDCT method and expressed as fold-level increase or decrease of gene expressions in T offspring versus that in control rats. All reactions were performed in duplicate, and bactin was used as an internal control.
Statistical Analysis
Differences in tension between PE contraction and basal tension were considered maximal tension (100 %), and relaxation to ACh was expressed as the percentage of relaxation from the maximal response induced by PE. Cumulative concentration-response curves were analyzed by computer fitting to a four-parameter sigmoid curve, using Prism 6 software (GraphPad, San Diego, CA) to evaluate the E max , the maximum asymptote of the curve. All values are means 6 SEM. For comparison, a two-way ANOVA test and a Bonferroni post hoc test were performed. A P value of ,0.05 was considered significant.
RESULTS

Plasma T and Ang II Levels and Ace Expression
Plasma T levels were significantly increased in T males (2.4 6 0.35 ng/ml; n ¼ 7; P 0.05) compared with that in controls (1.5 6 0.17 ng/ml; n ¼ 7). Plasma Ang II levels were significantly increased in T males (1.4 6 0.41 ng/ml; n ¼ 7; P 0.05) compared with that in controls (0.8 6 0.04 ng/ml; n ¼ 7). Ace mRNA expression was significantly increased in the kidney and mesenteric artery of T rats compared to that in controls (P , 0.05; n ¼ 5 in each group) (Fig. 1). MORE ET AL.
Effects of Enalapril Treatment on Systemic Blood Pressure
MAP was increased significantly in T rats (133 6 2.5 mm Hg; n ¼ 6) compared with that in control rats (119 6 2.3 mm Hg; n ¼ 7; P , 0.05) (Fig. 2) . Enalapril treatment did not affect MAP in control rats (113 6 4.2 mm Hg; n ¼ 7), but it significantly lowered MAP in T rats (115 6 4.5 mm Hg; n ¼ 7; P , 0.05) (Fig. 2) .
Effects of Enalapril Treatment on EDHF-Mediated Relaxation
In order to investigate EDHF-mediated relaxation in the rat mesenteric artery, we examined ACh-induced relaxation in the presence of L-NAME and indomethacin. ACh-induced EDHFmediated relaxation was significantly lower in rings from T rats (n ¼ 6, P 0.05) than in those from controls rats (n ¼ 6) (Fig. 3 and Table 1 ). Enalapril treatment caused no significant alteration in the EDHF relaxation in controls (n ¼ 6) (Fig. 3 and Table 1 ). In contrast, enalapril treatment of T rats led to a significant enhancement of the EDHF relaxation compared to that in untreated T rats (n ¼ 6) (Fig. 3 and Table 1 ).
Effects of Enalapril Treatment on Kcnn3 Channel Function
To examine the contribution of Kcnn3 channels in EDHFmediated relaxation, rings were incubated with apamin, a Kcnn3-channel inhibitor. Preincubation with apamin significantly attenuated ACh-induced EDHF relaxation to a similar magnitude in mesenteric arteries from control rats with and without enalapril treatment (n ¼ 6 in each group) (Fig. 4 , A and C, and Table 1 ). On the other hand, apamin did not affect EDHF relaxation in T rats not treated with enalapril, but it significantly attenuated the EDHF relaxation in T rats treated with enalapril (n ¼ 6-7 in each group) (Fig. 4 , B and D, and Table 1 ).
Effects of Enalapril Treatment on Kcnn4 Channel Function
To examine the part played by the Kcnn4 channel in the EDHF-mediated relaxation, rings were incubated with TRAM-34, a Kcnn4 channel inhibitor. Presence of TRAM-34 resulted in reductions in EDHF relaxation responses to a magnitude similar to that in the mesenteric arteries of controls and T rats with and without enalapril treatment (n ¼ 6-7 in each group) ( Fig. 5 and Table 1 ).
Effect of Enalapril Treatment on Endothelium-Independent Levcromakalim-Induced Relaxation Responses
Vascular relaxation to levcromakalim, an ATP-sensitive K þ channel opener used to determine the sensitivity of vascular smooth muscle cells to EDHF [39] , was not significantly different between the control and T rats with and without enalapril treatment (n ¼ 5 in each group) (Fig. 6 and Table 1 ).
Effect of Enalapril Treatment on Expression of Kcnn3 and Kcnn4
Kcnn3 expression was decreased by 50% in T rats (n ¼ 5; P 0.05) compared with that in controls (n ¼ 5) (Fig 7, left  panel) . Enalapril treatment increased Kcnn3 expression in T rats but did not have any effect in controls (n ¼ 5 in each group; P 0.05). Expression of Kcnn4 in control rats was not different from that in T rats (n ¼ 5) (Fig. 7) , and enalapril treatment did not have an effect on the expression of Kcnn4 in either controls or T rats (n ¼ 5) (Fig 7) . Our attempt to 
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determine Kcnn3 and Kcnn4 protein expression was less conclusive, with many bands at inappropriate molecular weights. Similar difficulties in determining Kcnn3 and Kcnn4 protein expression have been reported [40] .
DISCUSSION
We investigated the role of enalapril in modifying EDHFmediated relaxation responses in mesenteric arteries. The present study confirms our previous finding that prenatal T 
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exposure induces hypertension and impairs the endothelial EDHF component of vasodilation in resistance arteries [17] and expands on it by demonstrating that this impairment is reversed by enalapril treatment. In addition, we demonstrated that enalapril specifically restored the expression and function of the Kcnn3 channel in mesenteric arteries of prenatal Texposed rats. These findings could explain, at least in part, the importance of RAS signaling in EDHF dysfunction and to the elevated blood pressure observed in prenatal T-exposed rats [17, 36, 41, 42] .
It is well established that a variety of insults, when experienced in the prenatal period, can have long-term influences on the health of the individual. Factors, such as maternal undernutrition [43] and placental insufficiency [44] , which lead to impaired fetal growth, are known to cause hypertension and other cardiovascular abnormalities in the offspring. We and others have previously reported that elevated maternal T levels are an important stimulus for increased blood pressure in offspring [17, 36, 41, 42] . We not only confirmed the fact that elevated T levels in pregnant rats increase arterial pressure in the offspring, but we also provided a new finding that treatment with the ACE inhibitor enalapril abolished the hypertensive response, which suggests that RAS activation contributes, in part, to increased blood pressure in T rats. The finding of increased ACE expression in the kidney and mesenteric artery along with increased plasma levels of Ang II substantiates the fact that T rats have inappropriate RAS activation.
Because kidneys play an important role in long-term control of blood pressure [45] , the decrease in blood pressure in T rats following enalapril treatment could be due to renal ACE inhibition. To determine the effect of enalapril treatment on endothelial function, we examined EDHF function in isolated mesenteric arteries. We previously showed that prenatal T exposure led to endothelial dysfunction with specific impairments in EDHF function [17] . An endothelial dysfunction 
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involving a selective blunting of EDHF-mediated relaxation in the mesenteric artery has also been observed in spontaneously hypertensive rats [46] and in Ang II-treated rats [21] . In the present study, we observed that treatment with the ACE inhibitor enalapril prevented endothelial dysfunction in T rats, as indicated by normal EDHF-mediated relaxations in mesenteric arteries, suggesting that Ang II may be a causal factor contributing to the underlying impairment of the EDHFmediated response observed in T rats. This observation is consistent with the reported improvement in EDHF function in the conduit internal thoracic artery of hypertensive patients treated with ACE inhibitors [47] . The absence of differences in relaxation responses to levcromakalim between T and control rats with and without enalapril treatment suggests that the enhanced EDHF relaxation in T rats with enalapril is not due to increased vascular smooth muscle sensitivity to EDHF but may be related to improvement in EDHF generation.
Kcnn3 and Kcnn4 channels located in the endothelium are known to play an important role in initiation of hyperpolarization [2] [3] [4] [5] . We analyzed the effect of enalapril treatment on the EDHF function with the specific roles of Kcnn3 and Kcnn4 channels. The Kcnn3 channel contribution for EDHF relaxation was similar in controls with and without enalapril treatment, as apamin caused a similar magnitude of inhibition in these groups. The present findings of diminished EDHF relaxation and failure of apamin to alter EDHF relaxation in mesenteric arteries of T rats suggest that prenatal T exposure resulted in a loss of the regulatory role of Kcnn3 channels in initiating hyperpolarization. Our data also suggest that the loss of the regulatory role of Kcnn3 channels in mesenteric arteries of T rats resulted chiefly from reduced channel activities due to suppressed expression of these channels consistent with previous findings [17] . Interestingly, the present study shows that enalapril treatment to T rats restores activities of the Kcnn3 channel as the enhanced EDHF relaxation observed in enalapril-treated T rats was inhibited following Kcnn3 blockade (compared to Kcnn3 blockade, which had no effect in T rats not treated with enalapril). The present finding of enhanced Kcnn3 channel activities in EDHF-mediated relaxation in mesenteric arteries of enalapril-treated T rats correlates well with the restored expression of Kcnn3 channels. The effect of prenatal T exposure and enalapril treatment seems to be specific for Kcnn3 channels, as Kcnn4 channel expression and function were unaffected (TRAM-34 inhibits EDHF relaxation to a similar magnitude in control and T rats with and without enalapril treatment). Taken together, experimental evidence suggests that targeted suppression of Kcnn3 channels is a major mechanism for impaired EDHF relaxation in T rats and that enalapril treatment restores this effect. The present findings are in agreement with previous ones indicating that chronic infusion of Ang II to rats caused a selective downregulation of Kcnn3 levels and attenuation of the Kcnn3 component of EDHF relaxation [22] . It may be possible that the improvement in EDHF function observed in hypertensive patients treated with ACE inhibitor [47] may be due to an improvement in KCNN3 channel function. Presently, the mechanisms by which enalapril upregulates expression and function of Kcnn3 channels in mesenteric arteries of T rats are not clear. It is conceivable that inhibition of Ang II signaling may contribute to this upregulation. Ang II is known to attenuate vasodilator function via an AT 1 R/ superoxide-dependent pathway [48, 49] . However, reports are contradictory as reactive oxygen species are shown to have no effect [22] or decrease [50, 51] Kcnn3 channel expression and function. Furthermore, whether the improvement in Kcnn3 channel expression and function is the effect of inhibition of Ang II signaling or a consequence of an enalapril-induced decrease in blood pressure is difficult to discern. Bennett et al. [52] showed that long-term antihypertensive treatments with ACE inhibitors, not with hydralazine or amlodipine, increased relaxations in response to ACh and bradykinin in mesenteric 
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resistance arteries from spontaneously hypertensive rats. Thus, the effect of ACE inhibitors on endothelium-dependent relaxations seems to be independent, at least in part, of their antihypertensive actions. Further studies are needed to examine the exact mechanism by which enalapril regulates Kcnn3 channel expression and function.
In conclusion, the present study demonstrates that prenatal exposure to elevated androgen levels results in hypertension and blunting of the ability of endothelial cells to generate normal hyperpolarizing responses due to impairment of Kcnn3 channel function. These alterations were prevented by ACE inhibition with enalapril, indicating a negative influence of RAS on EDHF responses and specifically Kcnn3 function. These findings not only support the beneficial effects of RAS blockers in inhibiting direct vascular smooth muscle contractile effects but also offer an explanation for the beneficial effects on the endothelial EDHF function. We believe our findings should stimulate further interest in RAS blockade as a potential therapeutic target for use against small-vessel vasculopathy.
